OBJECTIVES: The goals of this project included identifying the processes and subprocesses performed in hospital pharmacies, identifying potential adverse events, detecting failure modes and the causes of errors, prioritising the risks identified and designing a map of risks for hospital pharmacies. METHODS: A task force composed of hospital pharmacy staff was committed to update the diagram of processes and design a map of processes performed in hospital pharmacies. Risks were identified by failure mode and effect analysis annd prioritised according to their risk priority index (RPI) and criticality. A risk map of adverse events was designed based on the diagram of processes and/or primary activities where the prioritised failure modes were most frequent. RESULTS: In total, 99 failure modes associated with 80 adverse events and 129 causes were identified in eight hospital pharmacy areas/subprocesses. The three areas with the highest percentages of failure modes were inpatient pharmaceutical care, pharmacy laboratory and pharmaceutical technology, and medication management. The 25 failure modes (first quartile) with the highest RPI scores (RPI≥20) and the 25 failure modes with the highest frequency and criticality scores were classified as priority. CONCLUSIONS: According to their RPI, priority failure modes mostly occurred in the area of inpatient pharmaceutical care (92%). However, according to their criticality, priority failure modes were found to homogeneously occur across all pharmaceutical care areas. As general recommendations pharmacists should assume responsibility and leadership in the implementation of safe medication use practices in healthcare centres.
OBJECTIVES: The goals of this project included identifying the processes and subprocesses performed in hospital pharmacies, identifying potential adverse events, detecting failure modes and the causes of errors, prioritising the risks identified and designing a map of risks for hospital pharmacies. METHODS: A task force composed of hospital pharmacy staff was committed to update the diagram of processes and design a map of processes performed in hospital pharmacies. Risks were identified by failure mode and effect analysis annd prioritised according to their risk priority index (RPI) and criticality. A risk map of adverse events was designed based on the diagram of processes and/or primary activities where the prioritised failure modes were most frequent. RESULTS: In total, 99 failure modes associated with 80 adverse events and 129 causes were identified in eight hospital pharmacy areas/subprocesses. The three areas with the highest percentages of failure modes were inpatient pharmaceutical care, pharmacy laboratory and pharmaceutical technology, and medication management. The 25 failure modes (first quartile) with the highest RPI scores (RPI≥20) and the 25 failure modes with the highest frequency and criticality scores were classified as priority. CONCLUSIONS: According to their RPI, priority failure modes mostly occurred in the area of inpatient pharmaceutical care (92%). However, according to their criticality, priority failure modes were found to homogeneously occur across all pharmaceutical care areas. As general recommendations pharmacists should assume responsibility and leadership in the implementation of safe medication use practices in healthcare centres.
Authors: Peter M Layde; Leslie M Cortes; Stephen P Teret; Karen J Brasel; Evelyn M Kuhn; James A Mercy; Stephen W Hargarten; Leslie A Maas Journal: JAMA Date: 2002-04-17 Impact factor: 56.272
Authors: J J Pérez Lázaro; I Fernández Ruiz; M Tejedor Fernández; J A Guerra de Hoyos; M Jiménez Rodríguez; M de Pazzis Die de Ortega; J Insausti Valdivia; M Rodríguez López; J Romero Cotelo; R Gálvez Mateos Journal: Rev Esp Anestesiol Reanim Date: 2012-06-27
Authors: Richard J Brilli; Richard E McClead; Wallace V Crandall; Linda Stoverock; Janet C Berry; T Arthur Wheeler; J Terrance Davis Journal: J Pediatr Date: 2013-07-30 Impact factor: 4.406
Authors: J J Pérez Lázaro; I Fernández Ruiz; M Tejedor Fernández; J A Guerra de Hoyos; M Jiménez Rodríguez; M de Pazzis Die de Ortega; J Insausti Valdivia; M Rodríguez López; J Romero Cotelo; R Gálvez Mateos Journal: Rev Esp Anestesiol Reanim Date: 2013-02-20
Authors: P J Saturno; Z A Da Silva Gama; S L de Oliveira-Sousa; Y A Fonseca; A C de Souza-Oliveira; Carmen Castillo; M José López; Teresa Ramón; Andrés Carrillo; M Dolores Iranzo; Victor Soria; Pedro J Saturno; Pedro Parra; Rafael Gomis; Juan José Gascón; José Martinez; Carmen Arellano; Zenewton A Da Silva Gama; Silvana L de Oliveira-Sousa; Adriana C de Souza-Oliveira; Yadira A Fonseca; Marta Sobral Ferreira Journal: Med Clin (Barc) Date: 2008-12 Impact factor: 1.725
Authors: Nenad Miljković; Brian Godman; Eline van Overbeeke; Milena Kovačević; Karyofyllis Tsiakitzis; Athina Apatsidou; Anna Nikopoulou; Cristina Garcia Yubero; Laura Portillo Horcajada; Gunar Stemer; Darija Kuruc-Poje; Thomas De Rijdt; Tomasz Bochenek; Isabelle Huys; Branislava Miljković Journal: Front Med (Lausanne) Date: 2020-05-12
Authors: Olga Fedorowicz; Łukasz Rypicz; Anna Wiela-Hojeńska; Ewa Jaźwińska-Tarnawska; Izabela Witczak Journal: Int J Environ Res Public Health Date: 2022-01-25 Impact factor: 3.390